Search Results
Search results for "Jana Selent"
Results found for "Jana Selent"
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
Selective or promiscuous, agonists or antagonists were for all 4 Adenosine Receptors were included in Design, Radiosynthesis, and Biodistribution of a New Potent and Selective Ligand for in Vivo Imaging Adenosine A2A Receptor Antagonists: From Caffeine to Selective Non‐xanthines.
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
For example, random mutagenesis, combined with novel specificity high-throughput selection, has been Furthermore, probing species- or subtype-selectivity introduces complexities due to the differing contexts Flipping the GPCR switch: Structure-based development of selective cannabinoid receptor 2 inverse agonists
- GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer
We identified gambogic acid (GA), a natural prenylated xanthone, selectively targeting GPR108. as a promising therapeutic target of cancer, and provided a small molecule inhibitor GA directly and selectively
- Crinetics Presents Clinical And Research Results At ENDO 2022
June 2022 "CRN04894 Selected for Oral Presentation SAN DIEGO, June 8, 2022 — Crinetics Pharmaceuticals adrenal hyperplasia (CAH) and other conditions driven by excess adrenocorticotropic hormone (ACTH), were selected
- Unlocking the Future of Medicine: Advancements in GPCR Research
Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate Selection multi-drug resistant Staphylococcus aureus Isolation, Structure Elucidation, and Biological Activity of the Selective ligand recognition in G-protein-coupled receptor subtypes Structural insights into ligand recognition, selectivity
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Deletion of phospholipase Cβ3 (PLCβ3), or selective inhibition of Gβγ regulation of PLCβ3, enhances the upstream regulators, Gβγ or Gq, ex vivo in periaqueductal gray (PAG) slices increased the potency of the selective
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Selective fluorescent CB1R ligands have been validated for flow cytometry [12], and selective CB2R probes To validate the potential of CELT-335 as a probe, seven reference compounds were selected. Table 2. The set of reference compounds were chosen to provide the highest diversification in affinity, selectivity 2017 , 376 (3), 235–242. https://doi.org/10.1056/NEJMoa1610300 . (10) Rosado, T.; Gonçalves ,Joana Protein Engineering Design and Selection 2006 , 19 (7), 309–316. https://doi.org/10.1093/protein/gzl014
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Higher specificity and reproducibility Well characterized ligands show consistent and selective binding Optimizing Fluorescence Channels and Fluorophore Selection for GPCR-Targeted Flow Cytometry The fluorophore
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
Naming what is deprioritized removes silent tension and reduces unnecessary expansion. 3️⃣ Treat strategic uncertainty does not quietly redirect the company without conscious choice. ✅ Biotech startups that avoid silent Founders who prevent silent failure do not wait for problems to surface. ✅ They continuously reinforce
- Fluorescence Polarization in GPCR Research
Using this method, binding affinity, kinetics and selectivity can all be measured and used to establish Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists. ACS Med Chem Lett. 2022 Jan 10;13(2):243-249. doi: 10.1021/acsmedchemlett.1c00598.
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Bryan Roth's work on "Built-in functional selectivity in neurons is mediated by the neuronal protein, GPCRs in Neuroscience Mu-opioid receptor selective superagonists produce prolonged respiratory depression Built-in functional selectivity in neurons is mediated by the neuronal protein, GINIP.
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
support vector machines which require handcrafted feature engineering, where domain experts manually select One major challenge is the identification of receptor subtype-selective ligands. In this context, BRS-3D was used to predict subtype-selective ligands for dopamine receptors and adenosine With the revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively data with GPCR-related knowledge, AI can help identify patient-specific GPCR targets and optimize drug selection
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
binding affinity experiments are interpreted—and how those interpretations quietly shape SAR, lead selection affinity experiments that tell the truth , ensuring affinity data support—rather than undermine—lead selection
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Michel Bouvier, J Silvio Gutkind, and team found that Gαs is essential for GRK selectivity and gene regulation signaling by a polypeptide hormone GPCR Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity spectroscopy with stable-isotope labeled receptors GPCR Binders, Drugs, and more Orthosteric ligand selectivity
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
We selected the adenosine receptor 2B (A2BAR), specifically expressed in cancer cell lines compared with Finally, we validated A2BAR as a potential pharmacological tool in CRC, using selective antagonists,
- 📰 GPCR Weekly News, September 18 to 24, 2023
Short talk selections will be announced soon. Abstract submissions close on October 2nd. GPCR Activation and Signaling Rules and mechanisms governing G protein coupling selectivity of GPCRs Molecular Insights into GPCR Function Cryo-EM structures of human GPR34 enable the identification of selective
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
question, we studied mice that express a Gs-coupled designer G protein-coupled receptor (Gs-DREADD or GsD) selectively CRF2 receptor) and studied the acute metabolic effects of activating these receptors in vivo by highly selective GsD signaling in SKM impaired glucose tolerance in lean and obese mice by decreasing glucose uptake selectively Conclusions: Selective activation of Gs signaling in SKM causes an acute increase in blood glucose levels
- 📰 GPCR Weekly News, July 24 to July 30, 2023
Lukas Grätz, David Gloriam, and Gunnar Schulte’s research on Unveiling pathway selectivity in Frizzleds GPCR Activation and Signaling Endosome positioning coordinates spatially selective GPCR signaling. Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Adenine-derived scaffolds enabled selective adenosine receptor antagonists; tryptophan modifications This reroutes discovery toward: Functionally selective ligands Better therapeutic windows More predictable
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
receptor (GPCR) pharmacogenomics Miles D Thompson , David Reiner-Link , Alessandro Berghella , Brinda K Rana Ben Jones , Johannes Broichhagen Design of allosteric modulators that change GPCR G protein subtype selectivity which recognized native receptor Design of allosteric modulators that change GPCR G protein subtype selectivity domains of mammalian adenylyl cyclases are lipid receptors Structural insights into endogenous ligand selectivity
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
Stimulation of AVPR2 with a selective agonist desmopressin promoted CRPC cell proliferation through cAMP In contrast, blocking AVPR2 with a selective FDA-approved antagonist, tolvaptan, reduced cell growth.
- Chemokine receptor-targeted drug discovery: progress and challenges
Proudfoot excluded the idea of molecular redundancy, pointing out that, in some cases, inappropriate target selection CKRs targeted drug discovery is the concept of biased agonism/antagonism, also known as functional selectivity Signaling bias can be seen as complex as advantageous since selectively inhibiting certain signaling
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
This distinction is essential for designing drugs that selectively target these residues to achieve desired evolutionary standpoint, the study reveals that residues critical for β2AR function are under intense selective
- California gold rush for Sosei Heptares
Neurocrine Biosciences anticipates initiating a Phase 2 study with the selective M4 agonist HTL-0016878 in schizophrenia in 2022 and Phase 1 studies for a dual M1/M4 and selective M1 agonist in 2023."
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Activation and Signaling The ancestral ESCRT protein TOM1L2 selects ubiquitinated cargoes for retrieval Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells. Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Receptors
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
The mambaquaretin-1 (MQ1) peptide identified from the Dendroaspis angusticeps venom is the most selective The number of MQ1 residues involved in V2R binding is large and may explain its absolute selectivity.
- Why Opposing Processes Matter for Your Next GPCR Drug
Ignore these forces, and your “selective” agonist may deliver surprises the first time it meets a patient This insight has huge implications for how you select and rank agonists in discovery campaigns.
- Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures
structures is applied to explore the impact of binding of agonists and antagonist/inverse agonists to selected
- Activation of GPR183 by 7 α,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through...
These effects are blocked by the selective small molecule GPR183 antagonist, SAE-14. the GPR183 agonist 7α,25-OHC induce behavioral hypersensitivity, and these effects are blocked by the selective
- Targeting the M1 muscarinic receptor in neurodegenerative disease
in cognitive and neurodegenerative disorders and the potential therapeutic benefit of muscarinic M1 selective












